Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Future CAGR is Anticipated for the Diabetes Diagnostics Market Over the 2025–2034 Period?

The market size for diabetes diagnostics has shown robust growth in the past few years. The market is predicted to expand from $25.39 billion in 2024 to reach a size of $27.39 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.9%. The substantial growth witnessed in the past was prompted by factors such as a rising rate of diabetes, growth in the elderly population, a surge in inactive lifestyles, an increase in the uptake of minimally invasive diagnostics, and an escalating prevalence of obesity.

In the upcoming years, the diabetes diagnostics market is anticipated to witness significant expansion. The market size is predicted to reach $36.72 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.6%. This projected growth is due to factors such as the increasing use of insulin pumps, advancements in diabetes technology, the rise in unhealthy lifestyle habits, and the increasing occurrence of type 1 and type 2 diabetes, in addition to the growing healthcare infrastructure. The forecast period is also expected to see major trends such as the advancement in biosensor technologies, technological progress, advancements in diagnostic technologies, personalized medicines and targeted therapies, and innovative technology in in vitro diagnostic products.

What External and Internal Drivers Are Contributing to the Growth of the Diabetes Diagnostics Market’s Growth?

The rise in obesity rates is anticipated to fuel the expansion of the diabetes diagnostics market. Obesity is defined as an excessive build-up of body fat, which escalates the potential for various health issues including heart disease and diabetes. Factors such as inactive lifestyles, an amplified intake of processed and high-calorie foods, genetic susceptibility, and inadequate physical exercise contribute to the higher prevalence of obesity. Diabetes diagnostics plays a critical role in managing obesity by early detection of insulin resistance and issues with glucose metabolism, thus facilitating prompt actions to prevent weight increase and associated health risks. For example, the Centers for Disease Control and Prevention, a government agency in the U.S., reported in September 2023, that in 2022, the obesity rate among adults in 22 states was 35% or more, marking a rise from 19 states in the previous year, 2021. Hence, the increased prevalence of obesity is stimulating the progression of the diabetes diagnostics market.

Explore Comprehensive Insights Into The Global Diabetes Diagnostics Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

Who Are the Influential Players Fueling Innovation and Growth in the Diabetes Diagnostics Market?

Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.

What Impact Are Industry Trends Having on the Diabetes Diagnostics Market’s Future Prospects?

Big names in the diabetes diagnostics market are concentrating their efforts on crafting innovative products, including gestational diabetes diagnostic devices, to broaden their offerings and satisfy the increasing need for early identification and control of diabetes during pregnancy. In the realm of medical devices and tests, these devices are utilized to spot and supervise gestational diabetes in expectant mothers, with predominant reliance on blood glucose tests like the oral glucose tolerance test (OGTT). This helps in gauging the efficiency of the body’s sugar processing during pregnancy. For instance, an innovative biosensor tool called XpressGT RUO kit was launched by DirectSens GmbH, an Austrian biotech firm, in August 2024. The tool, designed to detect conditions related to insulin resistance, such as gestational diabetes, endometriosis, and liver disease, provides prompt results by measuring 2-hydroxybutyrate (2-HB) in venous blood and is perfect for standard clinical analyzers. This pioneering development is expected to provide early detection and possibly enhance millions of patients’ health all over the world.

Secure Your Global Diabetes Diagnostics Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

How Are the Key Segments of the Diabetes Diagnostics Market Impacting Its Expansion and Revenue Streams?

The diabetes diagnostics market covered in this report is segmented –

1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

2) By Diabetes Type: Diabetes I, Diabetes II, Gestational Diabetes

3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-enabled Blood Glucose Meters

2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

3) By Lancets: Single-use Lancets, Multi-use Lancets

4) By Test Strips: Standard Test Strips, Smart Test Strips

5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

What Regions Are Leading the Growth Trajectory of the Diabetes Diagnostics Market?

North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Do Experts Define the Scope of the Diabetes Diagnostics Market?

Diabetes diagnostics refers to the methods and tests used to identify and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. It involves various medical assessments to detect abnormal glucose metabolism and assess the risk or presence of diabetes. Accurate diagnostics aid in early detection, disease management, and treatment planning.

Browse Through More Similar Reports By The Business Research Company:

Pertussis Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Influenza A Virus Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

Weight Loss Supplements Global Market Report 2025

https://thebusinessresearchcompany.com/report/weight-loss-supplements-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: